Back

Long term flecainide therapy in type-3 long QT syndrome

29 August 2016 (08:30 - 12:30)
Organised by:
Congress Presentation Part of: Poster session 4 - Miscellaneous in arrhythmia Antiarrhythmic drugs ESC Premium Access ESC Congress 2016

About the speaker

Photo
Doctor Ehud Chorin

Tel Aviv Sourasky Medical Center, Tel Aviv (Israel)

28 More presentations in this session

Presentation thumbnail
Doctor J. Ozawa (Niigata, JP)
Abstract
Presentation thumbnail
Associate Professor N. Marziliano (Garbagnate Milanese, IT)
Presentation thumbnail
Associate Professor N. Marziliano (Garbagnate Milanese, IT)
Presentation thumbnail
Doctor A. Hermida (Paris, FR)
Abstract
Presentation thumbnail
Doctor R. Mango (Rome, IT)
Abstract

Access the full session

Session thumbnail
Poster session 4 - Miscellaneous in arrhythmia

The Event

Event poster

ESC Congress 2016

29 August 2016 08:30 CET
You may be interested in
thumbnail
Congress Presentation
Is mexiletine ready for prime time in patients with Type 2 Long QT Syndrome?
28 August 2020
thumbnail
Congress Session
Genetics in heart failure
18 May 2025
thumbnail
Congress Presentation
Flecainide vs Amiodarone for the cardioversion of Atrial Fibrillation in the Emergency Department in patients with Coronary Artery Disease and preserved ejection fraction. FLECA-ED study
1 April 2025
thumbnail
Congress Presentation
Sodium bicarbonate and lipid emulsion for successful treatment of rare flecainide toxicity
15 March 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources